Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCode ▼DrugDate fromSubject
 10.11.2021Teva Czech Industries s.r.o. (TEV-CZ-2)00683THYMOMEL (sir 1x100 ml (fľ.skl.hnedá))23.11.2021R
 16.12.2021Teva Czech Industries s.r.o. (TEV-CZ-2)00683THYMOMEL (sir 1x100 ml (fľ.skl.hnedá))17.12.2021O
 16.11.2022Teva Czech Industries s.r.o. (TEV-CZ-2)00683THYMOMEL (sir 1x100 ml (fľ.skl.hnedá))26.12.2022R
 28.3.2023Teva Czech Industries s.r.o. (TEV-CZ-2)00683THYMOMEL (sir 1x100 ml (fľ.skl.hnedá))3.4.2023O
 15.4.2020Teva Czech Industries s.r.o. (TEV-CZ-2)00699CHOLAGOL (gto por 1x10 ml (fľ.skl.hnedá))4.6.2020R
 22.3.2021Teva Czech Industries s.r.o. (TEV-CZ-2)00699CHOLAGOL (gto por 1x10 ml (fľ.skl.hnedá))26.3.2021O
 4.2.2022Teva Czech Industries s.r.o. (TEV-CZ-2)00699CHOLAGOL (gto por 1x10 ml (fľ.skl.hnedá))31.1.2022R
 1.11.2023Fresenius Kabi s.r.o. (FRK-CZ-3)0069ACarboplatin Kabi 10 mg/ml (con inf 1x5 ml/50 mg (liek.inj.skl.))1.1.2024Z
 8.8.2022Zentiva a.s. (ZNT-SK-2)00720KANAVIT (gte por 1x5 ml/100 mg (fľ.skl.hnedá))8.8.2022R
 15.8.2022Zentiva a.s. (ZNT-SK-2)00720KANAVIT (gte por 1x5 ml/100 mg (fľ.skl.hnedá))16.8.2022O
 12.12.2022Zentiva a.s. (ZNT-SK-2)00720KANAVIT (gte por 1x5 ml/100 mg (fľ.skl.hnedá))12.12.2022R
 21.2.2023Zentiva a.s. (ZNT-SK-2)00720KANAVIT (gte por 1x5 ml/100 mg (fľ.skl.hnedá))24.2.2023O
 21.1.2021Nova Laboratories Ireland Limited (NLL-IE)0075AXaluprine 20 mg/ml perorálna suspenzia (sus por 1x100 ml (fľ.skl.jantár.+2 striek.inj.PET))25.11.2020Z
 17.8.2022Teva B.V. (TEV-NL-4)00802OPHTHALMO-SEPTONEX (int opo 1x10 ml (fľ.plast.biela+kvapkadlo))1.9.2022R
 16.5.2023Teva B.V. (TEV-NL-4)00802OPHTHALMO-SEPTONEX (int opo 1x10 ml (fľ.plast.biela+kvapkadlo))15.5.2023O

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)